Delivery Order SPE2DB25D3008-SPE2DB25FRCRR
Award Date 7/23/25
Potential Completion Date 8/13/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract ceiling value of $13,862.79. This competitive award, which carries a firm fixed-price structure and no set-aside designation, is scheduled for completion by September 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $13,862.79. This non-set-aside competitive award, with an ultimate completion date of August 18, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,620.93 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13.86K delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed price contract with no set-aside designation, scheduled for completion by September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that...
- This delivery order, valued at $9,241.86, awards AmerisourceBergen Drug Corp the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed price contract. The award was made competitively without set-aside designation and is set for completion by August 19, 2025. The Defense Logistics Agency, which handles medical supply chain procurement for the Department of Defense, is the funding federal agency, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,620.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a non-set-aside competitive award with an ultimate completion date of September 11, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count units) on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $4,620.93 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,466.57 firm fixed price delivery order contract to supply Zeposia 0.92 mg capsules. This order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...